Clinical Trials Directory

Trials / Terminated

TerminatedNCT02436590

Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee

A Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Orthofix Inc. · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of this study is that exposure to PEMF alters the cytokine environment of OA joints associated with a reduction of inflammation and improved homeostasis of the extracellular matrix (ECM), both potentially effecting symptomatic relief of OA pain, reducing cartilage breakdown, stimulate new cartilage formation therefore preserving joint structure.

Detailed description

The hypothesis of this study is that exposure to PEMF alters the cytokine environment of OA joints associated with a reduction of inflammation and improved homeostasis of the extracellular matrix (ECM), both potentially effecting symptomatic relief of OA pain, reducing cartilage breakdown, stimulate new cartilage formation therefore preserving joint structure. The primary objective of this study is to prospectively determine, at 12 months post treatment, the safety and efficacy of treating OA of the knee with PEMF. Safety will be assessed through adverse event collection. Study subjects will be randomized in a 2:1 ratio (active: placebo control) to either an active or placebo control (inactive) Physio-Stim device. The study is powered to detect a significant difference between groups when 120 subjects (80 active: 40 placebo control) have completed the study. Planned enrollment for the study is 150 subjects, to allow for an attrition rate of 20%.

Conditions

Interventions

TypeNameDescription
DEVICEOrthofix Physio-Stim Model 3315OAActive device emits PEMF signal; placebo/control device does not emit PEMF signal

Timeline

Start date
2016-01-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2015-05-07
Last updated
2020-07-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02436590. Inclusion in this directory is not an endorsement.